Thus, in current study we aimed to investigate whether patients with pulmonary sarcoidosis differ from those with EPS in routinely assessed clinical and laboratory data including HLA-DRB polymorphisms, FLC and TNF-α and IL-8 expression. The gene discussed is CXCL8; the disease is pulmonary sarcoidosis.